Two Sigma Advisers’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,600
| Closed | -$23K | – | 2547 |
|
|
2022
Q3 | $23K | Sell |
16,600
-10,900
| -40% | -$15.1K | ﹤0.01% | 2434 |
|
|
2022
Q2 | $60K | Buy |
27,500
+10,000
| +57% | +$21.8K | ﹤0.01% | 2458 |
|
|
2022
Q1 | $56K | Sell |
17,500
-43,800
| -71% | -$140K | ﹤0.01% | 2572 |
|
|
2021
Q4 | $257K | Sell |
61,300
-27,700
| -31% | -$116K | ﹤0.01% | 2191 |
|
|
2021
Q3 | $723K | Sell |
89,000
-52,300
| -37% | -$425K | ﹤0.01% | 1763 |
|
|
2021
Q2 | $1.07M | Sell |
141,300
-73,300
| -34% | -$554K | ﹤0.01% | 1606 |
|
|
2021
Q1 | $1.86M | Buy |
214,600
+67,500
| +46% | +$586K | 0.01% | 1298 |
|
|
2020
Q4 | $1.17M | Sell |
147,100
-47,900
| -25% | -$382K | ﹤0.01% | 1490 |
|
|
2020
Q3 | $1.56M | Buy |
195,000
+57,100
| +41% | +$455K | ﹤0.01% | 1289 |
|
|
2020
Q2 | $1.37M | Buy |
137,900
+27,400
| +25% | +$271K | ﹤0.01% | 1422 |
|
|
2020
Q1 | $854K | Sell |
110,500
-27,200
| -20% | -$210K | ﹤0.01% | 1570 |
|
|
2019
Q4 | $530K | Buy |
137,700
+31,100
| +29% | +$120K | ﹤0.01% | 1859 |
|
|
2019
Q3 | $536K | Sell |
106,600
-14,600
| -12% | -$73.4K | ﹤0.01% | 1690 |
|
|
2019
Q2 | $801K | Sell |
121,200
-10,200
| -8% | -$67.4K | ﹤0.01% | 1622 |
|
|
2019
Q1 | $995K | Sell |
131,400
-8,000
| -6% | -$60.6K | ﹤0.01% | 1530 |
|
|
2018
Q4 | $1.13M | Sell |
139,400
-28,900
| -17% | -$233K | ﹤0.01% | 1430 |
|
|
2018
Q3 | $2.17M | Sell |
168,300
-45,851
| -21% | -$591K | 0.01% | 1187 |
|
|
2018
Q2 | $2.44M | Buy |
+214,151
| New | +$2.44M | 0.01% | 1208 |
|